Amgen 2015 Annual Report Download - page 111

Download and view the complete annual report

Please find page 111 of the 2015 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 132

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132

F-33
Dividends
Our Board of Directors declared quarterly dividends per share of $0.79, $0.61, and $0.47 that were paid in each of the four
quarters of 2015, 2014, and 2013, respectively.
Historically, each year we have declared dividends in December that were paid in the first quarter of the following fiscal
year, and in March, July and October that were paid in the second, third and fourth quarters, respectively, of the same fiscal year.
Additionally, on December 15, 2015, the Board of Directors declared a quarterly cash dividend of $1.00 per share of common
stock, which will be paid on March 8, 2016, to all stockholders of record as of the close of business on February 16, 2016.
Accumulated other comprehensive income
The components of accumulated other comprehensive income (AOCI) were as follows (in millions):
Foreign
currency
translation
Cash flow
hedges
Available-for-
sale
securities Other AOCI
Balance as of December 31, 2012 $12$
(35) $ 183 $ (14) $ 146
Foreign currency translation adjustments (71) — — — (71)
Unrealized gains (losses) —88
(284)(1)(197)
Reclassification adjustments to income —(85)(75)—
(160)
Other ——— (2)(2)
Income taxes (9) (1) 133 — 123
Balance as of December 31, 2013 (68) (33)(43)(17)(161)
Foreign currency translation adjustments (218) — — — (218)
Unrealized gains — 298 37 1 336
Reclassification adjustments to income — 203 1 — 204
Other ———11
Income taxes 22 (178)(14)—
(170)
Balance as of December 31, 2014 (264) 290 (19)(15)(8)
Foreign currency translation adjustments (257) — — — (257)
Unrealized gains (losses) — 150 (299)8
(141)
Reclassification adjustments to income —(143)76 —(67)
Other ———11
Income taxes 10 — (18)— (8)
Balance as of December 31, 2015 $ (511) $ 297 $ (260)$ (6)$ (480)
Income tax expenses/benefits for unrealized gains and losses and the related reclassification adjustments to income for cash
flow hedges were a $53 million expense and $53 million benefit in 2015, a $104 million expense and $74 million expense in 2014
and a $34 million expense and $33 million benefit in 2013, respectively. Income tax expenses/benefits for unrealized gains and
losses and the related reclassification adjustments to income for available-for-sale securities were a $0 million and $18 million
expense for 2015, a $14 million expense and $0 million in 2014 and a $105 million benefit and $28 million benefit in 2013,
respectively.